Old age and Parkinson's disease

Handbook of Clinical Neurology

Volumn 84, Issue , 2007, Pages 427-444

  Rajput, Alex ^a   Rajput, Ali H ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649313805     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)84053-X     Document Type: Chapter

References (177)

1. Aarsland D., Andersen K., Larsen J.P., et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60 (2003) 387-392
2. Agid Y. Parkinson's disease: pathophysiology. Lancet 337 (1991) 1321-1324
3. Agid Y., Javoy-Agid F., and Ruberg M. Biochemistry of neurotransmitters in Parkinson's disease. In: Marsden C.D., and Fahn S. (Eds). Movement Disorders 2 (1987), Butterworths and Co, London 166-230
4. Agid Y., Cervera P., Hirsch E., et al. Biochemistry of Parkinson's disease 28 years later: a critical review. Mov Disord 4 (1989) S126-S144
5. Alarcon F., Zijlmans J.C., Duenas G., et al. Post-stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry 75 (2004) 1568-1574
6. Ayd F.J. A survey of drug-induced extrapyramidal reaction. JAMA 175 (1961) 1054-1060
7. Bain P.G., Findley L.J., Thompson P.D., et al. A study of hereditary essential tremor. Brain 117 (1994) 805-824
8. Baldereschi M., De Carlo A., Rocca W.A., et al. ILSA Working GroupParkinson's disease and parkinsonism in a longitudinal study. Two-fold higher incidence in men. Neurology 55 (2000) 1358-1363
9. Baloh R.W., Fife T.D., Zerling L., et al. Comparison of static and dynamic posturography in young and older normal people. J Am Geriatr Soc 42 4 (1994) 405-412
10. Bennett D.A., Beckett L.A., Murray A.M., et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 334 (1996) 71-76
11. Bennett R.G., Greenough W.B., Gloth F., et al. Extrapyramidal signs in dementia of Alzheimer type. Lancet 2 8676 (1989) 1392
12. Bergareche A., De La Puento E., Lopez de Munain A., et al. Prevalence of essential tremor: a door-to-door survey in Bidasoa, Spain. Neuroepidemiology 20 (2001) 125-128
13. Bharucha N.E., Bharucha A.E., Bharucha E.P., et al. Prevalence of Parkinson's disease in the Parsi Community of Bombay, India. Arch Neurol 45 (1988) 1321-1323
14. Birdi S., Rajput A.H., Fenton M., et al. Progressive supranuclear palsy diagnosis and confounding features-report on 16 autopsied cases. Mov Disord 17 6 (2002) 1255-1264
15. Birkmayer W., and Hornykiewicz O. The effect of L-3,4-dihydroxyphenylalanine (=L-DOPA) on akinesia in parkinsonism. Wien Klin Wochenschr 73 45 (1961) 787-788
16. Birkmayer W., and Hornykiewicz O. The effect of L-3, 4-dihydroxyphenylalanine (=DOPA) on akinesia in parkinsonism. Parkinsonism Relat Disord 4 (1998) 59-60
17. Blaschke T.F., Nies A.S., and Mamelok R.D. Principles of therapeutics. In: Gilman A.G., et al. (Ed). The Pharmacological Basis of Therapeutics. 7th edn (1985), McMillan Publishing Company, New York 49-65
18. Bloem B.R., Hausdorff J.M., Visser J.E., et al. Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord 19 8 (2004) 871-884
19. Bower J.H., Maraganore D.M., McDonnell S.K., et al. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 52 (1999) 1214-1220
20. Brooks D.J., Playford E.D., Ibanez V., et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology 42 (1992) 1554-1560
21. 18F-dopa PET study. Neurology 43 (1993) 552-556
22. Calzetti S., Baratti M., and Findley L.J. Frequency/amplitude characteristic of postural tremor of the hands in a population of patients with bilateral essential tremor: implications for the classification and mechanism of essential tremor. J Neurol Neurosurg Psychiatry 50 (1987) 561-567
23. Canadian Study of Health and Aging Working Group. Canadian study of health and aging: study methods and prevalence of dementia. CMAJ 150 6 (1994) 899-913
24. Cordes M., Snow B.J., Cooper S., et al. Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren. Ann Neurol 36 (1994) 667-670
25. Cotzias G.C., Van Woert M.H., and Schiffer L.M. Aromatic amino acids and modification of parkinsonism. N Engl J Med 276 (1967) 374-379
26. de la Monte S.M., Wells S.E., Hedley-Whyte E.T., et al. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. Ann Neurol 26 (1989) 309-320
27. de Rijk M.C., Rocca W.A., Anderson D.W., et al. A population perspective on diagnostic criteria for Parkinson's disease. Neurology 48 (1997) 1277-1281
28. Delay J., and Deniker P. Drug-induced extrapyramidal syndromes. In: Vinken P.J., and Bruyn G.W. (Eds). Handbook of Clinical Neurology. 6th edn. (1968), Elsevier, North Holland, Inc, New York 248-266
29. Della Sala S., Francescani A., and Spinnler H. Gait apraxia after bilateral supplementary motor area lesion. J Neurol Neurosurg Psychiatry 72 (2002) 77-85
30. Desai T., Rajput A.H., and Desai H.B. Use and abuse of drugs in the elderly. Prog Neuropsychopharmacol Biol Psychiatry 14 (1990) 779-784
31. Dogu O., Sevim S., Camdeviren H., et al. Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey. Neurology 61 (2003) 1804-1806
32. Drachman D.A., Long R.R., and Swearer J.M. Neurological evaluation of the elderly patient. In: Albert M.L., and Knoefel J.E. (Eds). Clinical Neurology of Aging. 2nd edn. (1994), Oxford University Press, New York 159-180
33. Du Pasquier R.A., Blanc Y., Sinnreich M., et al. The effect of aging on postural stability: a cross sectional and longitudinal study. Neurophysiol Clin 33 5 (2003) 213-218
34. Duncan G., and Wilson J.A. Extrapyramidal signs in normal elderly. Lancet 2 8676 (1989) 1392 (Letter to the Editor)
35. Duvoisin R.C. The differential diagnosis of parkinsonism. In: Stern G.M. (Ed). Parkinson's Disease (1990), The John Hopkins University Press, Baltimore 431-466
36. Duvoisin R.C., and Golbe L.I. Toward a definition of Parkinson's disease. Neurology 39 (1989) 746
37. Ehringer H., and Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in human brain: their behaviour in extrapyramidal system diseases. Klin Wochenschr 38 (1960) 1236-1239
38. Ehringer H., and Hornykiewicz O. Verteilung von noradrenalin und dopamin (3-hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems. Klin Wochenschr 38 (1960) 1236-1239
39. Ehringer H., and Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Parkinsonism Relat Disord 4 (1998) 53-57
40. Elble R.J. Physiologic and essential tremor. Neurology 36 (1986) 225-231
41. Elble R.J. Essential tremor frequency decreases with time. Neurology 55 (2000) 1547-1551
42. Estanol B.V. Gait apraxia in communicating hydrocephalus. J Neurol Neurosurg Psychiatry 44 (1981) 305-308
43. Fahn S., and Elton R.L. UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S., et al. (Ed). Recent Developments in Parkinson's disease. 2nd edn. (1987), Macmillan Healthcare Information, Florham Park, NJ 153-305
44. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (1991) 2283-2301
45. Findley L.J., and Gresty M.A. Tremor. Br J Hosp Med 26 (1981) 16-32
46. Findley L.J., and Koller W.C. Definitions and behavioral classifications. In: Koller W.C., and Findley L.J. (Eds). Handbook of Tremor Disorders (1995), Marcel Dekker Inc., New York 1-5
47. Findley L.J., Gresty M.A., and Halmagyi G.M. Tremor and cogwheel phenomena and clonus in Parkinson's disease. J Neurol Neurosurg Psychiatry 44 (1981) 534-546
48. Fisher C.M. Hydrocephalus as a cause of disturbances of gait in the elderly. Neurology 32 (1982) 1358-1363
49. Forssberg H., Johnels B., and Steg G. Is parkinsonian gait caused by a regression to an immature walking pattern?. In: Hasler R.G., and Christ J.F. (Eds). Advances in Neurology. 40th edn. (1984), Raven Press, New York 375-379
50. Fransson P.A., Kristinsdottir E.K., Hafstrom A., et al. Balance control and adaptation during vibratory perturbations in middle-aged and elderly humans. Eur J Appl Physiol 91 (2004) 595-603
51. Friedman J.H. Drug-induced parkinsonism. In: Lang A.E., and Weiner W.J. (Eds). Drug-Induced Movement Disorders (1992), Futura Publishing Co., Inc, Mount Kisco, New York 41-83
52. Fuente-Fernández R., Lu J., Sossi V., et al. Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover. Ann Neurol 49 (2001) 298-303
53. Gibb W.R.G. Neuropathology of the substantia nigra. Eur Neurol 31 Suppl 1 (1991) 48-59
54. Gibb W.R., and Lees A.J. A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 38 (1988) 1402-1406
55. Gibb W.R.G., and Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51 (1988) 745-752
56. Global Parkinson's Disease Survey (GPDS) Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 17 1 (2002) 60-67
57. Goetz C.G., Tanner C.M., Stebbins G.T., et al. Risk factors for progression in Parkinson's disease. Neurology 38 (1988) 1841-1844
58. Graybiel A.M., Hirsch E.C., and Agid Y. The nigrostriatal system in Parkinson's disease. Adv Neurol 53 (1990) 17-29
59. Haerer A.F., Anderson D.W., and Schoenberg B.S. Prevalence of essential tremor: results from the Copiah County Study. Arch Neurol 39 (1982) 750-751
60. Hallett M. Differential diagnosis of tremor. In: Vinken P.J., Bruyn G.W., and Klawans H.L. (Eds). Handbook of Clinical Neurology; Extrapyramidal Disorders. 49th edn. (1986), Elsevier Science Publishing Co., Inc, New York 583-595
61. Hardie R.J., and Lees A.J. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 51 (1988) 850-854
62. Hietanen M., and Teravainen H. The effect of age of disease onset on neuropsychological performance in Parkinson's disease. J Neurol Neurosurg Psychiatry 51 (1988) 244-249
63. Hobson P., and Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov Disord 19 9 (2004) 1043-1049
64. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression, and mortality. Neurology 17 (1967) 427-442
65. Hornykiewicz O., and Kish S.J. Biochemical pathophysiology of Parkinson's disease. In: Yahr M.D., and Bergmann K.J. (Eds). Advances in Neurology Vol. 45 (1986), Raven Press, New York 19-34
66. Hughes A.J., Daniel S.E., Kilford L., et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
67. Hughes A.J., Daniel S.E., Ben-Schlomo Y., et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125 (2002) 861-870
68. Jackson J.A., Jankovic J., and Ford J. Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Ann Neurol 13 (1983) 273-278
69. Jankovic J., and Fahn S. Physiologic and pathologic tremors Diagnosis, mechanism, and management. Ann Intern Med 93 (1980) 460-465
70. Jankovic J., McDermott M., Carter J., et al. Parkinson Study Group. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology 40 (1990) 1529-1534
71. Jankovic J., Rajput A.H., Golbe L.I., et al. What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis. Mov Disord 8 4 (1993) 525-532
72. Jankovic J., Beach J., Schwartz K., et al. Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. Neurology 45 (1995) 645-648
73. Jankovic J., Schwartz K.S., and Ondo W. Re-emergent tremor of Parkinson's disease. J Neurol Neurosurg Psychiatry 67 (1999) 646-650
74. Jellinger K. The pathology of parkinsonism. In: Marsden C.D., and Fahn S. (Eds). Movement Disorders 2 (1987), Butterworths and Co., London 124-165
75. Jenkyn L.R., Reeves A.G., Warren T., et al. Neurological signs in senescence. Arch Neurol 42 (1985) 1154-1157
76. Katsikitis M. A study of facial expression in Parkinson's disease using a novel microcomputer-based method. J Neurol Neurosurg Psychiatry 51 (1988) 362-366
77. Kelly J., Taggart H.M., and McCullagh P. Normal and abnormal tremor in the elderly. In: Findley L.J., and Koller W.C. (Eds). Handbook of Tremor Disorders (1995), Marcel Dekker, Inc, New York 351-370
78. Kischka U., Mandir A.S., Ghika J., et al. Electrophysiologic detection of extrapyramidal motor signs in Alzheimer's disease. Neurology 43 (1993) 500-505
79. Kish S.J., Shannak K., and Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med 318 (1988) 876-880
80. Kish S.J., Shannak K., Rajput A., et al. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. J Neurochem 58 (1992) 642-648
81. Klawans H.L. Abnormal movements in the elderly. Sandorama (Special Issue) 1 (1981) 5-18
82. Kline D., Sekuler R., and Dismukes K. Social issues, human needs, and opportunities for research on the effects of age on vision: an over-view. In: Sekuler R., Kline D., and Dismukes K. (Eds). Aging and Human Visual Function (1982), Alan R Liss, New York 3-6
83. Koller W.C., and Biary N. Effect of alcohol on tremors: comparison with propranolol. Neurology 34 (1984) 221-222
84. Koller W.C., Glatt S., Wilson R.S., et al. Primitive reflexes and cognitive function in the elderly. Ann Neurol 12 (1982) 302-304
85. Koller W.C., Wilson R., Glatt S., et al. Senile gait; correlation with computed tomographic scan. Ann Neurol 13 (1983) 343-344
86. Koller W.C., Hubble J.P., and Busenbark K.L. Essential tremor. In: Calne D.B. (Ed). Neurodegenerative Diseases (1994), WB Saunders Co., Philadelphia 717-742
87. Kostic V., Przedborski S., Flaster E., et al. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease. Neurology 41 (1991) 202-205
88. LeWitt P.A. Tremor induced or enhanced by pharmacological means. In: Findley L.J., and Koller W.C. (Eds). Handbook of Tremor Disorders (1995), Marcel Dekker, Inc, New York 473-481
89. Lexell J., Taylor C.C., and Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle for 15- to 83-year-old men. J Neurol Sci 84 (1988) 275-294
90. Louis E.D. Essential tremor. N Engl J Med 345 (2001) 887-891
91. Louis E.D., Marder K., Cote L., et al. Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY. Arch Neurol 52 (1995) 1201-1205
92. Louis E.D., Marder K., Cote L., et al. Prevalence of a history of shaking in persons 65 years of age and older: diagnostic and functional correlates. Mov Disord 11 (1996) 63-69
93. Luxon L.M. A bit dizzy. Br J Hosp Med 32 (1984) 315
94. Maki B.E., Holliday P.J., and Fernie G.R. Aging and postural control A comparison of spontaneous-and induced-sway balance tests. J Am Geriatr Soc 38 1 (1990) 1-9
95. Marder K., Leung D., Tang M., et al. Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis. Neurology 41 (1991) 1240-1243
96. Marsden C.D. Slowness of movement in Parkinson's disease. Mov Disord 4 Suppl 1 (1989) S26-S37
97. Martin W.E., Loewenson R.B., Resch J.A., et al. Parkinson's disease: clinical analysis of 100 patients. Neurology 23 (1973) 783-790
98. Marttila R.J. Epidemiology. In: Koller W.C. (Ed). Handbook of Parkinson's Disease (1987), Marcel Dekker, Inc, New York 35-50
99. Marttila R.J., and Rinne U.K. Dementia in Parkinson disease. Acta Neurol Scand 54 (1976) 431-441
100. Matjucha I., and Katz B. Neuro-ophthalmology of aging. In: Albert M.L., and Knoefel J.E. (Eds). Clinical Neurology of Aging. 2nd edn. (1994), Oxford University Press, New York 447
101. Mayeux R., Stern Y., Rosenstein R., et al. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Arch Neurol 45 (1988) 260-262
102. Mayeux R., Chen J., Mirabello E., et al. An estimate of the incidence of dementia in idiopathic Parkinson's disease. Neurology 40 (1990) 1513-1517
103. Mayeux R., Marder K., Cote L.J., et al. The frequency of idiopathic Parkinsons disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol 142 (1995) 820-827
104. Menz H.B., Lord S.R., and Fitzpatrick R.C. Age-related differences in walking stability. Age Ageing 32 2 (2003) 137-142
105. Mindham R.H.S., Ahmed S., and Clough C.G. A controlled study of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 45 (1982) 969-974
106. Moghal S., Rajput A.H., D'Arcy C., et al. Prevalence of movement disorders in elderly community residents. Neuroepidemiology 13 (1994) 175-178
107. Moghal S., Rajput A.H., Meleth R., et al. Prevalence of movement disorders in institutionalized elderly. Neuroepidemiology 14 (1995) 297-300
108. Molsa P.K., Marttila R.J., and Rinne U.K. Extrapyramidal signs in Alzheimer's disease. Neurology 34 (1984) 1114-1116
109. Morgante L., Rocca W.A., Di Rosa A.E., et al. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. Neurology 42 (1992) 1901-1907
110. Morris J.C., Drazner M., Fulling K., et al. Clinical and pathological aspects of parkinsonism in Alzheimer's disease. Arch Neurol 46 (1989) 651-657
111. Parker S.W. Dizziness in the elderly. In: Albert M.L., and Knoefel J.E. (Eds). Clinical Neurology of Aging. 2nd edn. (1994), Oxford University Press, New York 569-579
112. Quinn N. Multiple system atrophy-the nature of the beast. J Neurol Neurosurg Psychiatry 1 Special Suppl (1989) 78-89 7800
113. Rajput A.H. Levodopa in dystonia musculorum deformans. Lancet 1 (1973) 432
114. Rajput A.H. Drug induced parkinsonism in the elderly. Geriatr Med Today 3 (1984) 99-107
115. Rajput A.H. Parkinson's disease in the elderly. Med North Am 1 38 (1986) 101-106
116. Rajput A.H. Prevalence of dementia in Parkinson's disease. In: Huber S.J., and Cummings J.L. (Eds). Parkinson's Disease. Neurobehavioral Aspects (1992), Oxford University Press, New York 119-131
117. Rajput A.H. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 56 (1993) 938-939
118. Rajput A.H. Diagnosis of PD. Letter. Neurology 43 (1993) 1629-1630
119. Rajput A.H. Parkinsonism, aging and gait apraxia. In: Stern M.B., and Koller W.C. (Eds). Parkinsonian Syndromes (1993), Marcel Dekker, Inc, New York 511-532
120. Rajput A.H. Clinical features and natural history of Parkinson's disease (special consideration of aging). In: Calne D.B. (Ed). Neurodegenerative Diseases. 1st edn (1994), WB Saunders Company, Philadelphia 555-571
121. Rajput A.H. Clinical features of tremor in extrapyramidal syndromes. In: Findley L.J., and Koller W.C. (Eds). Handbook of Tremor Disorders (1994), Marcel Dekker, Inc, New York 275-291
122. Rajput A.H. Levodopa prolongs life expectancy and is non-toxic to substantia nigra. Parkinsonism Relat Disord 8 (2001) 95-100
123. Rajput A.H. Contributions of human brain biochemical studies to movement disorders. Parkinsonism Relat Disord 8 (2002) 425-431
124. Rajput A.H., and Rajput A. Movement disorders and aging. In: Watts R.L., and Koller W.C. (Eds). Movement Disorders. Neurologic Principles & Practice. 2nd edn. (2004), McGraw-Hill, New York 837-853
125. Rajput A.H., and Rozdilsky B. Parkinsonism and dementia: effects of L-dopa. Lancet 1 (1975) 1084
126. Rajput A.H., Kazi K.H., and Rozdilsky B. Striatonigral degeneration response to levodopa therapy. J Neurol Sci 16 (1972) 331-341
127. Rajput A.H., Jamieson H., Hirsch S., et al. Relative efficacy of alcohol and propranolol in action tremor. Can J Neurol Sci 2 (1975) 31-35
128. Rajput A.H., Rozdilsky B., Hornykiewicz O., et al. Reversible drug-induced parkinsonism Clinicopathologic study of two cases. Arch Neurol 39 (1982) 644-646
129. Rajput A.H., Offord K.P., Beard C.M., et al. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol 16 (1984) 278-282
130. Rajput A.H., Offord K.P., Beard C.M., et al. Essential tremor in Rochester, Minnesota: a 45-year study. J Neurol Neurosurg Psychiatry 47 (1984) 466-470
131. Rajput A.H., Stern W., and Laverty W.H. Chronic low dose therapy in Parkinson's disease: an argument for delaying levodopa therapy. Neurology 34 8 (1984) 991-996
132. Rajput A.H., Offord K.P., Beard C.M., et al. A case control study of smoking habits, dementia and other illnesses in idiopathic Parkinson's disease. Neurology 37 (1987) 226-232
133. Rajput A.H., Uitti R.J., Sudhakar S., et al. Parkinsonism and neurofibrillary tangle pathology in pigmented Nuclei. Ann Neurol 25 (1989) 602-606
134. Rajput A.H., Rozdilsky B., and Ang L. Site(s) of lesion and resting tremor. Ann Neurol 28 No. 2 (1990) 296-297
135. Rajput A.H., Rozdilsky B., and Rajput A.H. Essential leg tremor. Neurology 40 (1990) 1909
136. Rajput A.H., Rozdilsky B., Rajput A., et al. Levodopa efficacy and pathological basis of Parkinson syndrome. Clin Neuropharmacol 13 6 (1990) 553-558
137. Rajput A.H., Rozdilsky B., and Ang L. Occurrence of resting tremor in Parkinson's disease. Neurology 41 (1991) 1298-1299
138. Rajput A.H., Rozdilsky B., Ang L., et al. Clinicopathological observations in essential tremor. Report of 6 cases. Neurology 41 (1991) 1422-1424
139. Rajput A.H., Rozdilsky B., and Rajput A. Accuracy of clinical diagnosis in parkinsonism-a prospective study. Can J Neurol Sci 18 (1991) 275-278
140. Rajput A.H., Pahwa R., Pahwa P., et al. Prognostic significance of the onset mode in parkinsonism. Neurology 43 (1993) 829-830
141. Rajput A.H., Rozdilsky B., Ang L., et al. Significance of parkinsonian manifestations in essential tremor. Can J Neurol Sci 20 (1993) 114-117
142. Rajput A.H., Rozdilsky B., and Rajput A. Alzheimer's disease and idiopathic Parkinson's disease coexistence. J Geriatr Psychiatry Neurol 6 (1993) 170-176
143. Rajput A.H., Uitti R.J., Rajput A.H., et al. Timely levodopa (LD) administration prolongs survival in Parkinson's disease. Parkinsonism Relat Disord 3 3 (1997) 159-165
144. Rajput A.H., Fenton M.E., Birdi S., et al. Clinical-pathological study of levodopa complications. Mov Disord 17 2 (2002) 289-296
145. Rajput A.H., Fenton M.E., Di Paolo T., et al. Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off. Parkinsonism Relat Disord 10 (2004) 221-226
146. Rajput A., Robinson C., and Rajput A.H. Essential tremor course and disability: a clinicopathological study of 20 cases. Neurology 62 (2004) 932-936
147. Rautakorpi I., Marttila R.J., Takala J., et al. Occurrences and causes of tremors. Neuroepidemiology 1 (1982) 209-215
148. Rautakorpi I., Takala J., Marttila R.J., et al. Essential tremor in a Finnish population. Acta Neurol Scand 66 (1982) 58-67
149. Robinson C.A., and Rajput A.H. The Neuropathology of Parkinson's Disease and Other Parkinsonian Disorders Vol. 8493 (2005), CRC Press, Boca Raton 1590-1595
150. Rocca W.A., Bower J.H., McDonnell S.K., et al. Time trends in the incidence of parkinsonism in Olmsted County, Minnesota. Neurology 57 (2001) 462-467
151. Ross G.W., Petrovitch H., Abbott R.D., et al. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol 56 (2004) 532-539
152. Rowe J.W. Aging and geriatric medicine. In: Wyngaarden J.B., and Smith L.H. (Eds). Cecil Textbook of Medicine (1988), WB Saunders, Philadelphia 21-27
153. Salemi G., Savettieri G., Rocca W.A., et al. Prevalence of essential tremor: a door-to-door survey in Terrasini, Sicily. Neurology 44 1 (1994) 61-64
154. Schaafsma J.D., Balash Y., Gurevich T., et al. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease. Eur J Neurol 10 4 (2003) 391-398
155. Scherman D., Desnos C., Darchen F., et al. Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann Neurol 26 (1989) 551-557
156. Schoenberg B.S., Anderson D.W., and Haerer A.F. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology 35 6 (1985) 841-845
157. Schott J.M., and Rossor M.N. The grasp and other primitive reflexes. J Neurol Neurosurg Psychiatry 74 (2003) 558-560
158. Simons G., Pasqualini M.C., Reddy V., et al. Emotional and non-emotional facial expressions in people with Parkinson's disease. J Int Neuropsychol Soc 10 (2004) 521-535
159. Soininen H., Laulumaa V., Helkala E.L., et al. Extrapyramidal signs in Alzheimer's disease: a 3-year follow-up study. J Neural Transm Park Dis Dement Sect 4 2 (1992) 107-119
160. Steele J.C., Richardson J.C., and Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10 (1964) 333-359
161. Stern G. Prognosis in Parkinson's disease. In: Marsden C.D., and Fahn S. (Eds). Movement Disorders 2 (1987), Butterworth and Co. Ltd, London 91-98
162. Stiles R.N. Frequency and displacement amplitude relations for normal hand tremor. J Appl Physiol 40 1 (1976) 44-54
163. Sudarsky L. Geriatrics: gait disorders in the elderly. N Engl J Med 322 (1990) 1441-1446
164. Sudarsky L. Gait disturbances in the elderly. In: Albert M.L., and Knoefel J.E. (Eds). Clinical Neurology of Aging. 2nd edn. (1994), Oxford University Press, New York 483-492
165. Sudarsky L., and Ronthal M. Gait disorders among elderly patients A survey study of 50 patients. Arch Neurol 40 (1983) 740-743
166. Sudarsky L., and Simon S. Gait disorder in late-life hydrocephalus. Arch Neurol 44 (1987) 263-267
167. Suteerawattananon M., Morris G.S., Etnyre B.R., et al. Effects of visual and auditory cues on gait in individuals with Parkinson's disease. J Neurol Sci 219 1-2 (2004) 63-69
168. Tinetti M.E., Speechley M., and Ginter S.F. Risk factors for falls among elderly persons living in the community. N Engl J Med 319 (1988) 1701-1707
169. Tyrrell P.J., and Rossor M.N. Extrapyramidal signs in dementia of Alzheimer type. Lancet 2 8668 (1989) 920
170. Uitti R.J., Ahlskog J.E., Maraganore D.M., et al. Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project. Neurology 43 (1993) 1918-1926
171. Uitti R.J., Rajput A.H., Ahlskog J.E., et al. Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. Neurology 46 (1996) 1551-1556
172. Webster D.D. Critical analysis of disability in Parkinson's disease. Mod Treat 5 2 (1968) 257-282
173. Weiner W.J., Nora L.M., and Glantz R.H. Elderly inpatients: postural reflex impairment. Neurology 34 (1984) 945-947
174. Whitman G.T., Tang T., Lin A., et al. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 57 (2001) 990-994
175. Wilson R.S., Schneider J.A., Beckett L.A., et al. Progression of gait disorder and rigidity and risk of death in older persons. Neurology 58 (2002) 1815-1819
176. Winter D.A., Patla A.E., Frank J.S., et al. Biomechanical walking pattern changes in the fit and healthy elderly. Phys Ther 70 6 (1990) 340-347
177. Zetusky W.J., Jankovic J., and Pirozzolo F.J. The Heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 35 (1985) 522-526